Alcohol-Induced Plasticity in the Dynorphin/Kappa-opioid Receptor system

Frontiers in Molecular Neuroscience

Volumn , Issue AUG 2012, 2012, Pages 1-29

  Sirohi, Sunil ^a   Bakalkin, Georgy ^d   Walker, Brendan M ^a,b,c  

^a Laboratory of Alcoholism and Addictions Neuroscience   (United States)

^b Graduate Program in Neuroscience   (United States)

^c WASHINGTON STATE UNIVERSITY   (United States)

^d UPPSALA UNIVERSITY   (Sweden)

Author keywords

Alcohol; Amygdala; Anhedonic; Dependence; Depression; Dynorphin; Epigenetic; Ethanol; Kappa opioid receptor; Molecular mechanisms; Negative affect; Negative reinforcement; Nucleus accumbens; Operant; Oprk1; Orbitofrontal cortex; Pdyn; Prefrontal cortex; Prodynorphin; Self administration; Withdrawal

Indexed keywords

BETA ENDORPHIN; BRAIN DERIVED NEUROTROPHIC FACTOR; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; DYNORPHIN; KAPPA OPIATE RECEPTOR; MESSENGER RNA; OPIATE; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR FOSB; ALCOHOL;

ADAPTATION; ALCOHOL CONSUMPTION; ALCOHOL INDUCED PLASTICITY; ALCOHOL SEEKING; ALCOHOLISM; AMYGDALOID NUCLEUS; ANXIETY; ARTICLE; CHRONIC ALCOHOL EXPOSURE; DECISION MAKING; DRINKING BEHAVIOR; EMOTION; ENVIRONMENTAL FACTOR; EPIGENETICS; GENE EXPRESSION REGULATION; GENETIC REGULATION; HUMAN; LONG TERM EXPOSURE; MOOD DISORDER; MOTIVATION; NERVE CELL PLASTICITY; NEUROADAPTATION; NEUROSCIENCE; NONHUMAN; NUCLEUS ACCUMBENS; PATHOPHYSIOLOGY; PREFRONTAL CORTEX; SENSITIZATION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; UPREGULATION; ADAPTIVE BEHAVIOR; BRAIN REGION; DNA METHYLATION; EMOTIONALITY; NEUROMODULATION; NEUROPHARMACOLOGY; REVIEW; TRANSCRIPTION INITIATION;

EID: 84865970356     PISSN: 16625099     EISSN: None     Source Type: Journal    
DOI: 10.3389/fnmol.2012.00095     Document Type: Article

References (174)

1. Al-Hasani, R., and Bruchas, M. R. (2011). Molecular mechanisms of opioid receptor-dependent signaling and behavior. Anesthesiology 115, 1363-1381.
2. Altar, C. A., Siuciak, J. A., Wright, P., Ip, N. Y., Lindsay, R. M., and Wiegand, S. J. (1994). In situ hybridization of trkB and trkC receptor mRNA in rat forebrain and association with high-affinity binding of [125I]BDNF, [125I]NT-4/5 and [125I]NT-3. Eur. J. Neurosci. 6, 1389-1405.
3. Amalric, M., Cline, E. J., Martinez, J. L., Jr., Bloom, F. E., and Koob, G. F. (1987). Rewarding properties of beta-endorphin as measured by conditioned place preference. Psychopharmacology (Berl) 91, 14-19.
4. Bazov, I., Kononenko, O., Watanabe, H., Kuntic, V., Sarkisyan, D., Taqi, M. M., Hussain, M. Z., Nyberg, F., Yakovleva, T., and Bakalkin, G. (2011). The endogenous opioid system in human alcoholics: molecular adaptations in brain areas involved in cognitive control of addiction. Addict. Biol. doi: 10.1111/j.1369-1600.2011.00366.x
5. Bencherif, B., Wand, G. S., McCaul, M. E., Kim, Y. K., Ilgin, N., Dannals, R. F., and Frost, J. J. (2004). Mu-opioid receptor binding measured by [11C]carfentanil positron emission tomography is related to craving and mood in alcohol dependence. Biol. Psychiatry 55, 255-262.
6. Berger, B., Rothmaier, A. K., Wedekind, F., Zentner, J., Feuerstein, T. J., and Jackisch, R. (2006). Presynaptic opioid receptors on noradrenergic and serotonergic neurons in the human as compared to the rat neocortex. Br. J. Pharmacol. 148, 795-806.
7. Berger, S. L., Kouzarides, T., Shiekhattar, R., and Shilatifard, A. (2009). An operational definition of epigenetics. Genes Dev. 23, 781-783.
8. Boettiger, C. A., Kelley, E. A., Mitchell, J. M., D'Esposito, M., and Fields, H. L. (2009). Now or Later? An fMRI study of the effects of endogenous opioid blockade on a decision-making network. Pharmacol. Biochem. Behav. 93, 291-299.
9. Bolanos, C. A., Barrot, M., Berton, O., Wallace-Black, D., and Nestler, E. J. (2003). Methylphenidate treatment during pre-and periadolescence alters behavioral responses to emotional stimuli at adulthood. Biol. Psychiatry 54, 1317-1329.
10. Borrelli, E., Nestler, E. J., Allis, C. D., and Sassone-Corsi, P. (2008). Decoding the epigenetic language of neuronal plasticity. Neuron 60, 961-974.
11. Bouchery, E. E., Harwood, H. J., Sacks, J. J., Simon, C. J., and Brewer, R. D. (2011). Economic costs of excessive alcohol consumption in the U.S., 2006. Am. J. Prev. Med. 41, 516-524.
12. Bruchas, M. R., Schindler, A. G., Shankar, H., Messinger, D. I., Miyatake, M., Land, B. B., Lemos, J. C., Hagan, C. E., Neumaier, J. F., Quintana, A., Palmiter, R. D., and Chavkin, C. (2011). Selective p38alpha MAPK deletion in serotonergic neurons produces stress resilience in models of depression and addiction. Neuron 71, 498-511.
13. Bruijnzeel, A. W. (2009). kappa-Opioid receptor signaling and brain reward function. Brain Res. Rev. 62, 127-146.
14. Carelli, R. M. (2002). Nucleus accumbens cell firing during goal-directed behaviors for cocaine vs. 'natural' reinforcement. Physiol Behav. 76, 379-87.
15. Carlezon, W. A., Jr., Beguin, C., DiNieri, J. A., Baumann, M. H., Richards, M. R., Todtenkopf, M. S., Rothman, R. B., Ma, Z., Lee, D. Y., and Cohen, B. M. (2006). Depressive-like effects of the kappa-opioid receptor agonist salvinorin A on behavior and neurochemistry in rats. J. Pharmacol. Exp. Ther. 316, 440-447.
16. Carlezon, W. A., Jr., Duman, R. S., and Nestler, E. J. (2005). The many faces of CREB. Trends Neurosci. 28, 436-445.
17. Carlezon, W. A., Jr., Mague, S. D., and Andersen, S. L. (2003). Enduring behavioral effects of early exposure to methylphenidate in rats. Biol. Psychiatry 54, 1330-1337.
18. Carlezon, W. A., Jr., Thome, J., Olson, V. G., Lane-Ladd, S. B., Brodkin, E. S., Hiroi, N., Duman, R. S., Neve, R. L., and Nestler, E. J. (1998). Regulation of cocaine reward by CREB. Science 282, 2272-2275.
19. Carroll, M. R., Rodd, Z. A., Murphy, J. M., and Simon, J. R. (2006). Chronic ethanol consumption increases dopamine uptake in the nucleus accumbens of high alcohol drinking rats. Alcohol 40, 103-109.
20. Caudle, R. M., and Mannes, A. J. (2000). Dynorphin: friend or foe? Pain 87, 235-239.
21. Chao, M. V. (2003). Neurotrophins and their receptors: a convergence point for many signalling pathways. Nat. Rev. Neurosci. 4, 299-309.
22. Chavkin, C., James, I. F., and Goldstein, A. (1982). Dynorphin is a specific endogenous ligand of the kappa opioid receptor. Science 215, 413-415.
23. Chen, F., and Lawrence, A. J. (2000). Effect of chronic ethanol and withdrawal on the mu-opioid receptor-and 5-Hydroxytryptamine(1A) receptor-stimulated binding of [(35)S]Guanosine-5'-O-(3thio)triphosphate in the fawn-hooded rat brain: A quantitative autoradiography study. J. Pharmacol. Exp. Ther. 293, 159-165.
24. Chu, N. S., and Keenan, L. (1987). Responses of midbrain dorsal raphe neurons to ethanol studied in brainstem slices. Alcohol 4, 373-374.
25. Ciccocioppo, R., Gehlert, D. R., Ryabinin, A., Kaur, S., Cippitelli, A., Thorsell, A., Le, A. D., Hipskind, P. A., Hamdouchi, C., Lu, J., Hembre, E. J., Cramer, J., Song, M., McKinzie, D., Morin, M., Economidou, D., Stopponi, S., Cannella, N., Braconi, S., Kallupi, M., de, G. G., Massi, M., George, D. T., Gilman, J., Hersh, J., Tauscher, J. T., Hunt, S. P., Hommer, D., and Heilig, M. (2009). Stress-related neuropeptides and alcoholism: CRH, NPY, and beyond. Alcohol 43, 491-498.
26. Colombo, G., Addolorato, G., Agabio, R., Carai, M. A., Pibiri, F., Serra, S., Vacca, G., and Gessa, G. L. (2004). Role of GABA(B) receptor in alcohol dependence: reducing effect of baclofen on alcohol intake and alcohol motivational properties in rats and amelioration of alcohol withdrawal syndrome and alcohol craving in human alcoholics. Neurotox. Res. 6, 403-414.
27. Connor, M., and Christie, M. D. (1999). Opioid receptor signalling mechanisms. Clin. Exp. Pharmacol. Physiol 26, 493-499.
28. Cowen, M. S., and Lawrence, A. J. (2006). Alcoholism and neuropeptides: an update. CNS. Neurol. Disord. Drug Targets. 5, 233-239.
29. Crain, S. M., and Shen, K. F. (1990). Opioids can evoke direct receptor-mediated excitatory as well as inhibitory effects on sensory neuron action potentials. NIDA Res. Monogr 105, 34-39.
30. Dai, X., Thavundayil, J., and Gianoulakis, C. (2005). Differences in the peripheral levels of beta-endorphin in response to alcohol and stress as a function of alcohol dependence and family history of alcoholism. Alcohol Clin. Exp. Res. 29, 1965-1975.
31. Di, C. G., Bassareo, V., Fenu, S., De Luca, M. A., Spina, L., Cadoni, C., Acquas, E., Carboni, E., Valentini, V., and Lecca, D. (2004). Dopamine and drug addiction: the nucleus accumbens shell connection. Neuropharmacology 47 Suppl 1, 227-241.
32. Di, C. G., and Imperato, A. (1988). Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc. Natl. Acad. Sci. U. S. A 85, 5274-5278.
33. Dubner, R., and Ruda, M. A. (1992). Activity-dependent neuronal plasticity following tissue injury and inflammation. Trends Neurosci. 15, 96-103.
34. Eccleston, A., DeWitt, N., Gunter, C., Marte, B., and Nath, D. (2007). Epigenetics. Nature 447, doi:10.1038/447395a.
35. Faden, A. I., and Jacobs, T. P. (1983). Dynorphin induces partially reversible paraplegia in the rat. Eur. J. Pharmacol. 91, 321-324.
36. Fields, H. L., Hjelmstad, G. O., Margolis, E. B., and Nicola, S. M. (2007). Ventral tegmental area neurons in learned appetitive behavior and positive reinforcement. Annu. Rev. Neurosci. 30, 289-316.
37. Frankhuijzen, A. L., Jansen, F. P., Schoffelmeer, A. N. M., and Mulder, A. H. (1991). mu-Opioid receptor-mediated inhibition of the release of radiolabelled noradrenaline and acetylcholine from rat amygdala slices. Neurochemistry International 19, 543-548.
38. Funk, C. K., and Dohrman, D. P. (2007). Chronic ethanol exposure inhibits dopamine release via effects on the presynaptic actin cytoskeleton in PC12 cells. Brain Res. 1185, 86-94.
39. Funk, C. K., O'Dell, L. E., Crawford, E. F., and Koob, G. F. (2006). Corticotropin-releasing factor within the central nucleus of the amygdala mediates enhanced ethanol self-administration in withdrawn, ethanol-dependent rats. J. Neurosci. 26, 11324-11332.
40. Gianoulakis, C., Krishnan, B., and Thavundayil, J. (1996). Enhanced sensitivity of pituitary beta-endorphin to ethanol in subjects at high risk of alcoholism. Arch. Gen. Psychiatry 53, 250-257.
41. Gilpin, N. W., and Roberto, M. (2012). Neuropeptide modulation of central amygdala neuroplasticity is a key mediator of alcohol dependence. Neurosci. Biobehav. Rev. 36, 873-888.
42. Gorwood, P., Batel, P., Ades, J., Hamon, M., and Boni, C. (2000). Serotonin transporter gene polymorphisms, alcoholism, and suicidal behavior. Biol. Psychiatry 48, 259-264.
43. Grant, B. F., Dawson, D. A., Stinson, F. S., Chou, S. P., Dufour, M. C., and Pickering, R. P. (2004). The 12-month prevalence and trends in DSM-IV alcohol abuse and dependence: United States, 1991-1992 and 2001-2002. Drug Alcohol Depend. 74, 223-234.
44. Grant, B. F., and Harford, T. C. (1995). Comorbidity between DSM-IV alcohol use disorders and major depression: results of a national survey. Drug Alcohol Depend. 39, 197-206.
45. Grilli, M., Neri, E., Zappettini, S., Massa, F., Bisio, A., Romussi, G., Marchi, M., and Pittaluga, A. (2009). Salvinorin A exerts opposite presynaptic controls on neurotransmitter exocytosis from mouse brain nerve terminals. Neuropharmacology 57, 523-530.
46. Hauser, K. F., Aldrich, J. V., Anderson, K. J., Bakalkin, G., Christie, M. J., Hall, E. D., Knapp, P. E., Scheff, S. W., Singh, I. N., Vissel, B., Woods, A. S., Yakovleva, T., and Shippenberg, T. S. (2005). Pathobiology of dynorphins in trauma and disease. Front Biosci. 10, 216-235.
47. Healey, J. C., Winder, D. G., and Kash, T. L. (2008). Chronic ethanol exposure leads to divergent control of dopaminergic synapses in distinct target regions. Alcohol 42, 179-190.
48. Heinz, A., Beck, A., Wrase, J., Mohr, J., Obermayer, K., Gallinat, J., and Puls, I. (2009). Neurotransmitter systems in alcohol dependence. Pharmacopsychiatry 42 Suppl 1, S95-S101.
49. Hellman, A., and Chess, A. (2010). Extensive sequence-influenced DNA methylation polymorphism in the human genome. Epigenetics. Chromatin. 3, 11.
50. Hensler, J. G. (2006). Serotonergic modulation of the limbic system. Neurosci. Biobehav. Rev. 30, 203-214.
51. Hjelmstad, G. O., and Fields, H. L. (2001). Kappa opioid receptor inhibition of glutamatergic transmission in the nucleus accumbens shell. J. Neurophysiol. 85, 1153-1158.
52. Hjelmstad, G. O., and Fields, H. L. (2003). Kappa opioid receptor activation in the nucleus accumbens inhibits glutamate and GABA release through different mechanisms. J. Neurophysiol. 89, 2389-2395.
53. Hope, B. T., Nye, H. E., Kelz, M. B., Self, D. W., Iadarola, M. J., Nakabeppu, Y., Duman, R. S., and Nestler, E. J. (1994). Induction of a long-lasting AP-1 complex composed of altered Fos-like proteins in brain by chronic cocaine and other chronic treatments. Neuron 13, 1235-1244.
54. Hull, E. M., Lorrain, D. S., Du, J., Matuszewich, L., Lumley, L. A., Putnam, S. K., and Moses, J. (1999). Hormone-neurotransmitter interactions in the control of sexual behavior. Behav. Brain Res. 105, 105-116.
55. Hyytia, P., and Kiianmaa, K. (2001). Suppression of ethanol responding by centrally administered CTOP and naltrindole in AA and Wistar rats. Alcohol Clin. Exp. Res. 25, 25-33.
56. Jackisch, R., Geppert, M., and Illes, P. (1986). Characterization of opioid receptors modulating noradrenaline release in the hippocampus of the rabbit. J. Neurochem. 46, 1802-1810.
57. Jarjour, S., Bai, L., and Gianoulakis, C. (2009). Effect of acute ethanol administration on the release of opioid peptides from the midbrain including the ventral tegmental area. Alcohol Clin. Exp. Res. 33, 1033-1043.
58. John, G., Hegarty, J. P., Yu, W., Berg, A., Pastor, D. M., Kelly, A. A., Wang, Y., Poritz, L. S., Schreiber, S., Koltun, W. A., and Lin, Z. (2011). NKX2-3 variant rs11190140 is associated with IBD and alters binding of NFAT. Mol. Genet. Metab 104, 174-179.
59. Johnson, B. A. (2004). Role of the serotonergic system in the neurobiology of alcoholism: implications for treatment. CNS. Drugs 18, 1105-1118.
60. Kaminsky, Z., Tochigi, M., Jia, P., Pal, M., Mill, J., Kwan, A., Ioshikhes, I., Vincent, J. B., Kennedy, J. L., Strauss, J., Pai, S., Wang, S. C., and Petronis, A. (2011). A multi-tissue analysis identifies HLA complex group 9 gene methylation differences in bipolar disorder. Mol. Psychiatry.
61. Kelley, A. E., Bakshi, V. P., Haber, S. N., Steininger, T. L., Will, M. J., and Zhang, M. (2002). Opioid modulation of taste hedonics within the ventral striatum. Physiol Behav. 76, 365-377.
62. Kelley, A. E., Baldo, B. A., Pratt, W. E., and Will, M. J. (2005). Corticostriatal-hypothalamic circuitry and food motivation: integration of energy, action and reward. Physiol Behav. 86, 773-795.
63. Kelz, M. B., Chen, J., Carlezon, W. A., Jr., Whisler, K., Gilden, L., Beckmann, A. M., Steffen, C., Zhang, Y. J., Marotti, L., Self, D. W., Tkatch, T., Baranauskas, G., Surmeier, D. J., Neve, R. L., Duman, R. S., Picciotto, M. R., and Nestler, E. J. (1999). Expression of the transcription factor deltaFosB in the brain controls sensitivity to cocaine. Nature 401, 272-276.
64. Kelz, M. B., and Nestler, E. J. (2000). deltaFosB: a molecular switch underlying long-term neural plasticity. Curr. Opin. Neurol. 13, 715-720.
65. Kerkel, K., Spadola, A., Yuan, E., Kosek, J., Jiang, L., Hod, E., Li, K., Murty, V. V., Schupf, N., Vilain, E., Morris, M., Haghighi, F., and Tycko, B. (2008). Genomic surveys by methylation-sensitive SNP analysis identify sequence-dependent allele-specific DNA methylation. Nat. Genet. 40, 904-908.
66. Knoll, A. T., and Carlezon, W. A. (2010). Dynorphin, stress, and depression. Brain Res. 1314, 56-73.
67. Koob, G. F. (2000). Neurobiology of addiction. Toward the development of new therapies. Ann. N. Y. Acad. Sci. 909, 170-85.
68. Koob, G. F. (2004). A role for GABA mechanisms in the motivational effects of alcohol. Biochem. Pharmacol. 68, 1515-1525.
69. Koob, G. F. (2009). Dynamics of neuronal circuits in addiction: reward, antireward, and emotional memory. Pharmacopsychiatry 42 Suppl 1, S32-S41.
70. Koob, G. F. (2010). The role of CRF and CRF-related peptides in the dark side of addiction. Brain Res. 1314, 3-14.
71. Koob, G. F., and Bloom, F. E. (1988). Cellular and molecular mechanisms of drug dependence. Science 242, 715-723.
72. Koob, G. F., and Le, M. M. (2008). Addiction and the brain antireward system. Annu. Rev. Psychol. 59, 29-53.
73. Koob, G. F., and Weiss, F. (1992). Neuropharmacology of cocaine and ethanol dependence. Recent Dev. Alcohol 10, 201-233.
74. Lai, J., Ossipov, M. H., Vanderah, T. W., Malan, T. P., Jr., and Porreca, F. (2001). Neuropathic pain: the paradox of dynorphin. Mol. Interv. 1, 160-167.
75. Lam, M. P., Marinelli, P. W., Bai, L., and Gianoulakis, C. (2008). Effects of acute ethanol on opioid peptide release in the central amygdala: an in vivo microdialysis study. Psychopharmacology (Berl) 201, 261-271.
76. Land, B. B., Bruchas, M. R., Lemos, J. C., Xu, M., Melief, E. J., and Chavkin, C. (2008). The dysphoric component of stress is encoded by activation of the dynorphin kappa-opioid system. J. Neurosci. 28, 407-414.
77. Land, B. B., Bruchas, M. R., Schattauer, S., Giardino, W. J., Aita, M., Messinger, D., Hnasko, T. S., Palmiter, R. D., and Chavkin, C. (2009). Activation of the kappa opioid receptor in the dorsal raphe nucleus mediates the aversive effects of stress and reinstates drug seeking. Proc. Natl. Acad. Sci. U. S. A 106, 19168-19173.
78. Li, C., Pleil, K. E., Stamatakis, A. M., Busan, S., Vong, L., Lowell, B. B., Stuber, G. D., and Kash, T. L. (2012). Presynaptic inhibition of gamma-aminobutyric acid release in the bed nucleus of the stria terminalis by kappa opioid receptor signaling. Biol. Psychiatry 71, 725-732.
79. Lindholm, S., Ploj, K., Franck, J., and Nylander, I. (2000). Repeated ethanol administration induces short-and long-term changes in enkephalin and dynorphin tissue concentrations in rat brain. Alcohol 22, 165-171.
80. Lindholm, S., Rosin, A., Dahlin, I., Georgieva, J., and Franck, J. (2007). Ethanol alters the effect of kappa receptor ligands on dopamine release in the nucleus accumbens. Physiol Behav. 92, 167-171.
81. Lindholm, S., Werme, M., Brene, S., and Franck, J. (2001). The selective kappa-opioid receptor agonist U50,488H attenuates voluntary ethanol intake in the rat. Behav. Brain Res. 120, 137-146.
82. Logrip, M. L., Janak, P. H., and Ron, D. (2008). Dynorphin is a downstream effector of striatal BDNF regulation of ethanol intake. FASEB J. 22, 2393-2404.
83. Lonze, B. E., and Ginty, D. D. (2002). Function and regulation of CREB family transcription factors in the nervous system. Neuron 35, 605-623.
84. Love, T. M., Stohler, C. S., and Zubieta, J. K. (2009). Positron emission tomography measures of endogenous opioid neurotransmission and impulsiveness traits in humans. Arch. Gen. Psychiatry 66, 1124-1134.
85. Mague, S. D., Pliakas, A. M., Todtenkopf, M. S., Tomasiewicz, H. C., Zhang, Y., Stevens, W. C., Jr., Jones, R. M., Portoghese, P. S., and Carlezon, W. A., Jr. (2003). Antidepressant-like effects of kappa-opioid receptor antagonists in the forced swim test in rats. J. Pharmacol. Exp. Ther. 305, 323-330.
86. Malberg, J. E., and Blendy, J. A. (2005). Antidepressant action: to the nucleus and beyond. Trends Pharmacol. Sci. 26, 631-638.
87. Maldonado, R. (2003). The neurobiology of addiction. J. Neural Transm. Suppl 1-14.
88. Margolis, E. B., Hjelmstad, G. O., Bonci, A., and Fields, H. L. (2003). Kappa-opioid agonists directly inhibit midbrain dopaminergic neurons. J. Neurosci. 23, 9981-9986.
89. Margolis, E. B., Lock, H., Chefer, V. I., Shippenberg, T. S., Hjelmstad, G. O., and Fields, H. L. (2006). Kappa opioids selectively control dopaminergic neurons projecting to the prefrontal cortex. Proc. Natl. Acad. Sci. U. S. A 103, 2938-2942.
90. Marinelli, P. W., Bai, L., Quirion, R., and Gianoulakis, C. (2005). A microdialysis profile of Met-enkephalin release in the rat nucleus accumbens following alcohol administration. Alcohol Clin. Exp. Res. 29, 1821-1828.
91. Marinelli, P. W., Lam, M., Bai, L., Quirion, R., and Gianoulakis, C. (2006). A microdialysis profile of dynorphin A(1-8) release in the rat nucleus accumbens following alcohol administration. Alcohol Clin. Exp. Res. 30, 982-990.
92. Marinelli, P. W., Quirion, R., and Gianoulakis, C. (2003). A microdialysis profile of beta-endorphin and catecholamines in the rat nucleus accumbens following alcohol administration. Psychopharmacology (Berl) 169, 60-67.
93. Marinelli, P. W., Quirion, R., and Gianoulakis, C. (2004). An in vivo profile of beta-endorphin release in the arcuate nucleus and nucleus accumbens following exposure to stress or alcohol. Neuroscience 127, 777-784.
94. Martin-Trujillo, A., Iglesias-Platas, I., Coto, E., Corral-Juan, M., San, N. H., Corral, J., Volpini, V., Matilla-Duenas, A., and Monk, D. (2011). Genotype of an individual single nucleotide polymorphism regulates DNA methylation at the TRPC3 alternative promoter. Epigenetics. 6, 1236-1241.
95. Martinowich, K., Manji, H., and Lu, B. (2007). New insights into BDNF function in depression and anxiety. Nat. Neurosci. 10, 1089-1093.
96. Matsushita, S., Kimura, M., Miyakawa, T., Yoshino, A., Murayama, M., Masaki, T., and Higuchi, S. (2004). Association study of brain-derived neurotrophic factor gene polymorphism and alcoholism. Alcohol Clin. Exp. Res. 28, 1609-1612.
97. McBride, W. J., and Li, T. K. (1998). Animal models of alcoholism: neurobiology of high alcohol-drinking behavior in rodents. Crit Rev. Neurobiol. 12, 339-369.
98. McClung, C. A., and Nestler, E. J. (2008). Neuroplasticity mediated by altered gene expression. Neuropsychopharmacology 33, 3-17.
99. Merg, F., Filliol, D., Usynin, I., Bazov, I., Bark, N., Hurd, Y. L., Yakovleva, T., Kieffer, B. L., and Bakalkin, G. (2006). Big dynorphin as a putative endogenous ligand for the kappa-opioid receptor. J. Neurochem. 97, 292-301.
100. Misra, K., and Pandey, S. C. (2006). The decreased cyclic-AMP dependent-protein kinase A function in the nucleus accumbens: a role in alcohol drinking but not in anxiety-like behaviors in rats. Neuropsychopharmacology 31, 1406-1419.
101. Misra, K., Roy, A., and Pandey, S. C. (2001). Effects of voluntary ethanol intake on the expression of Ca(2+) /calmodulin-dependent protein kinase IV and on CREB expression and phosphorylation in the rat nucleus accumbens. Neuroreport 12, 4133-7413.
102. Moratalla, R., Elibol, B., Vallejo, M., and Graybiel, A. M. (1996). Network-level changes in expression of inducible Fos-Jun proteins in the striatum during chronic cocaine treatment and withdrawal. Neuron 17, 147-156.
103. Mucha, R. F., and Herz, A. (1985). Motivational properties of kappa and mu opioid receptor agonists studied with place and taste preference conditioning. Psychopharmacology (Berl) 86, 274-280.
104. Mulder, A. H., Wardeh, G., Hogenboom, F., and Frankhuyzen, A. L. (1984). Kappa-and delta-opioid receptor agonists differentially inhibit striatal dopamine and acetylcholine release. Nature 308, 278-280.
105. Nair, A., and Vaidya, V. A. (2006). Cyclic AMP response element binding protein and brain-derived neurotrophic factor: molecules that modulate our mood? J. Biosci. 31, 423-434.
106. Nealey, K. A., Smith, A. W., Davis, S. M., Smith, D. G., and Walker, B. M. (2011). kappa-opioid receptors are implicated in the increased potency of intra-accumbens nalmefene in ethanol-dependent rats. Neuropharmacology 61, 35-42.
107. Nestler, E. J. (2008). Review. Transcriptional mechanisms of addiction: role of DeltaFosB. Philos. Trans. R. Soc. Lond B Biol. Sci. 363, 3245-3255.
108. Nestler, E. J., Barrot, M., and Self, D. W. (2001). DeltaFosB: a sustained molecular switch for addiction. Proc. Natl. Acad. Sci. U. S. A 98, 11042-11046.
109. Nestler, E. J., and Carlezon, W. A., Jr. (2006). The mesolimbic dopamine reward circuit in depression. Biol. Psychiatry 59, 1151-1159.
110. Newton, S. S., Thome, J., Wallace, T. L., Shirayama, Y., Schlesinger, L., Sakai, N., Chen, J., Neve, R., Nestler, E. J., and Duman, R. S. (2002). Inhibition of cAMP response element-binding protein or dynorphin in the nucleus accumbens produces an antidepressant-like effect. J. Neurosci. 22, 10883-10890.
111. Nye, H. E., and Nestler, E. J. (1996). Induction of chronic Fos-related antigens in rat brain by chronic morphine administration. Mol. Pharmacol. 49, 636-645.
112. O'Dell, L. E., Roberts, A. J., Smith, R. T., and Koob, G. F. (2004). Enhanced alcohol self-administration after intermittent versus continuous alcohol vapor exposure. Alcohol Clin. Exp. Res. 28, 1676-1682.
113. O'Malley, S. S., Krishnan-Sarin, S., Farren, C., Sinha, R., and Kreek, M. J. (2002). Naltrexone decreases craving and alcohol self-administration in alcohol-dependent subjects and activates the hypothalamopituitary-adrenocortical axis. Psychopharmacology (Berl) 160, 19-29.
114. Pandey, S. C., Zhang, H., Roy, A., and Xu, T. (2005). Deficits in amygdaloid cAMP-responsive element-binding protein signaling play a role in genetic predisposition to anxiety and alcoholism. J. Clin. Invest 115, 2762-2773.
115. Perrotti, L. I., Weaver, R. R., Robison, B., Renthal, W., Maze, I., Yazdani, S., Elmore, R. G., Knapp, D. J., Selley, D. E., Martin, B. R., Sim-Selley, L., Bachtell, R. K., Self, D. W., and Nestler, E. J. (2008). Distinct patterns of DeltaFosB induction in brain by drugs of abuse. Synapse 62, 358-369.
116. Pfeiffer, A., Brantl, V., Herz, A., and Emrich, H. M. (1986). Psychotomimesis mediated by kappa opiate receptors. Science 233, 774-776.
117. Pistis, M., Muntoni, A. L., Gessa, G., and Diana, M. (1997). Effects of acute, chronic ethanol and withdrawal on dorsal raphe neurons: electrophysiological studies. Neuroscience 79, 171-176.
118. Pliakas, A. M., Carlson, R. R., Neve, R. L., Konradi, C., Nestler, E. J., and Carlezon, W. A., Jr. (2001). Altered responsiveness to cocaine and increased immobility in the forced swim test associated with elevated cAMP response element-binding protein expression in nucleus accumbens. J. Neurosci. 21, 7397-7403.
119. Przewlocka, B., Turchan, J., Lason, W., and Przewlocki, R. (1997). Ethanol withdrawal enhances the prodynorphin system activity in the rat nucleus accumbens. Neurosci. Lett. 238, 13-16.
120. Rawls, S. M., McGinty, J. F., and Terrian, D. M. (1999). Presynaptic kappa-opioid and muscarinic receptors inhibit the calcium-dependent component of evoked glutamate release from striatal synaptosomes. J. Neurochem. 73, 1058-1065.
121. Regier, D. A., Farmer, M. E., Rae, D. S., Locke, B. Z., Keith, S. J., Judd, L. L., and Goodwin, F. K. (1990). Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. JAMA 264, 2511-2518.
122. Renthal, W., and Nestler, E. J. (2008). Epigenetic mechanisms in drug addiction. Trends Mol. Med. 14, 341-350.
123. Reyes, B. A., Chavkin, C., and van Bockstaele, E. J. (2009). Subcellular targeting of kappa-opioid receptors in the rat nucleus locus coeruleus. J. Comp Neurol. 512, 419-431.
124. Reynard, L. N., Bui, C., Canty-Laird, E. G., Young, D. A., and Loughlin, J. (2011). Expression of the osteoarthritis-associated gene GDF5 is modulated epigenetically by DNA methylation. Hum. Mol. Genet. 20, 3450-3460.
125. Roberts, A. J., Heyser, C. J., Cole, M., Griffin, P., and Koob, G. F. (2000). Excessive ethanol drinking following a history of dependence: animal model of allostasis. Neuropsychopharmacology 22, 581-594.
126. Robison, A. J., and Nestler, E. J. (2011). Transcriptional and epigenetic mechanisms of addiction. Nat. Rev. Neurosci. 12, 623-637.
127. Rosin, A., Lindholm, S., Franck, J., and Georgieva, J. (1999). Downregulation of kappa opioid receptor mRNA levels by chronic ethanol and repetitive cocaine in rat ventral tegmentum and nucleus accumbens. Neurosci. Lett. 275, 1-4.
128. Roth, T. L., and Sweatt, J. D. (2009). Regulation of chromatin structure in memory formation. Curr. Opin. Neurobiol. 19, 336-342.
129. Saland, L. C., Abeyta, A., Frausto, S., Raymond-Stintz, M., Hastings, C. M., Carta, M., Valenzuela, C. F., and Savage, D. D. (2004). Chronic ethanol consumption reduces delta-and mu-opioid receptor-stimulated G-protein coupling in rat brain. Alcohol Clin. Exp. Res. 28, 98-104.
130. Schoffelmeer, A. N., Hogenboom, F., and Mulder, A. H. (1997). Kappa1-and kappa2-opioid receptors mediating presynaptic inhibition of dopamine and acetylcholine release in rat neostriatum. Br. J. Pharmacol. 122, 520-524.
131. Schwarzer, C. (2009). 30 years of dynorphins--new insights on their functions in neuropsychiatric diseases. Pharmacol. Ther. 123, 353-370.
132. Shibasaki, M., Inoue, M., Kurokawa, K., Ogou, S., and Ohkuma, S. (2010). Expression of serotonin transporter in mice with ethanol physical dependency. J. Pharmacol. Sci. 114, 234-237.
133. Shippenberg, T. S., Bals-Kubik, R., and Herz, A. (1987). Motivational properties of opioids: evidence that an activation of delta-receptors mediates reinforcement processes. Brain Res. 436, 234-239.
134. Shippenberg, T. S., and Rea, W. (1997). Sensitization to the behavioral effects of cocaine: modulation by dynorphin and kappa-opioid receptor agonists. Pharmacol. Biochem. Behav. 57, 449-455.
135. Shippenberg, T. S., Zapata, A., and Chefer, V. I. (2007). Dynorphin and the pathophysiology of drug addiction. Pharmacol. Ther. 116, 306-321.
136. Shoemaker, R., Deng, J., Wang, W., and Zhang, K. (2010). Allele-specific methylation is prevalent and is contributed by CpG-SNPs in the human genome. Genome Res. 20, 883-889.
137. Siggins, G. R., Martin, G., Roberto, M., Nie, Z., Madamba, S., and De, L. L. (2003). Glutamatergic transmission in opiate and alcohol dependence. Ann. N. Y. Acad. Sci. 1003, 196-211.
138. Singh, I. N., Goody, R. J., Goebel, S. M., Martin, K. M., Knapp, P. E., Marinova, Z., Hirschberg, D., Yakovleva, T., Bergman, T., Bakalkin, G., and Hauser, K. F. (2003). Dynorphin A (1-17) induces apoptosis in striatal neurons in vitro through alpha-amino-3-hydroxy-5-methylisoxazole-4propionate/kainate receptor-mediated cytochrome c release and caspase-3 activation. Neuroscience 122, 1013-1023.
139. Solomon, R. L., and Corbit, J. D. (1974). An opponent-process theory of motivation. I. Temporal dynamics of affect. Psychol. Rev. 81, 119-145.
140. Spanagel, R. (2009). Alcoholism: a systems approach from molecular physiology to addictive behavior. Physiol Rev. 89, 649-705.
141. Spanagel, R., Herz, A., and Shippenberg, T. S. (1992). Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway. Proc. Natl. Acad. Sci. U. S. A 89, 2046-2050.
142. Sperling, R. E., Gomes, S. M., Sypek, E. I., Carey, A. N., and McLaughlin, J. P. (2010). Endogenous kappa-opioid mediation of stress-induced potentiation of ethanol-conditioned place preference and self-administration. Psychopharmacology (Berl) 210, 199-209.
143. Stromberg, M. F., Casale, M., Volpicelli, L., Volpicelli, J. R., and O'Brien, C. P. (1998). A comparison of the effects of the opioid antagonists naltrexone, naltrindole, and beta-funaltrexamine on ethanol consumption in the rat. Alcohol 15, 281-289.
144. Tan-No, K., Cebers, G., Yakovleva, T., Hoon, G. B., Gileva, I., Reznikov, K., Aguilar-Santelises, M., Hauser, K. F., Terenius, L., and Bakalkin, G. (2001). Cytotoxic effects of dynorphins through nonopioid intracellular mechanisms. Exp. Cell Res. 269, 54-63.
145. Tan-No, K., Takahashi, H., Nakagawasai, O., Niijima, F., Sato, T., Satoh, S., Sakurada, S., Marinova, Z., Yakovleva, T., Bakalkin, G., Terenius, L., and Tadano, T. (2005). Pronociceptive role of dynorphins in uninjured animals: N-ethylmaleimide-induced nociceptive behavior mediated through inhibition of dynorphin degradation. Pain 113, 301-309.
146. Tao, R., and Auerbach, S. B. (2005). mu-Opioids disinhibit and kappa-opioids inhibit serotonin efflux in the dorsal raphe nucleus. Brain Res. 1049, 70-79.
147. Taqi, M. M., Bazov, I., Watanabe, H., Nyberg, F., Yakovleva, T., and Bakalkin, G. (2011a). Prodynorphin promoter SNP associated with alcohol dependence forms noncanonical AP-1 binding site that may influence gene expression in human brain. Brain Res. 1385, 18-25.
148. Taqi, M. M., Bazov, I., Watanabe, H., Sheedy, D., Harper, C., Alkass, K., Druid, H., Wentzel, P., Nyberg, F., Yakovleva, T., and Bakalkin, G. (2011b). Prodynorphin CpG-SNPs associated with alcohol dependence: elevated methylation in the brain of human alcoholics. Addict. Biol. 16, 499-509.
149. Tejeda, H. A., Shippenberg, T. S., and Henriksson, R. (2012). The dynorphin/kappa-opioid receptor system and its role in psychiatric disorders. Cell Mol. Life Sci. 69, 857-896.
150. Thiele, T. E., Willis, B., Stadler, J., Reynolds, J. G., Bernstein, I. L., and McKnight, G. S. (2000). High ethanol consumption and low sensitivity to ethanol-induced sedation in protein kinase A-mutant mice. J. Neurosci. 20, RC75.
151. Tomso, D. J., and Bell, D. A. (2003). Sequence context at human single nucleotide polymorphisms: overrepresentation of CpG dinucleotide at polymorphic sites and suppression of variation in CpG islands. J. Mol. Biol. 327, 303-308.
152. Turchan, J., Przewlocka, B., Toth, G., Lason, W., Borsodi, A., and Przewlocki, R. (1999). The effect of repeated administration of morphine, cocaine and ethanol on mu and delta opioid receptor density in the nucleus accumbens and striatum of the rat. Neuroscience 91, 971-977.
153. Uhl, G. R., Liu, Q. R., Walther, D., Hess, J., and Naiman, D. (2001). Polysubstance abuse-vulnerability genes: genome scans for association, using 1,004 subjects and 1,494 single-nucleotide polymorphisms. Am. J. Hum. Genet. 69, 1290-1300.
154. Ursini, G., Bollati, V., Fazio, L., Porcelli, A., Iacovelli, L., Catalani, A., Sinibaldi, L., Gelao, B., Romano, R., Rampino, A., Taurisano, P., Mancini, M., Di, G. A., Popolizio, T., Baccarelli, A., De, B. A., Blasi, G., and Bertolino, A. (2011). Stress-related methylation of the catechol-O-methyltransferase Val 158 allele predicts human prefrontal cognition and activity. J. Neurosci. 31, 6692-6698.
155. Uzbay, I. T. (2008). Serotonergic anti-depressants and ethanol withdrawal syndrome: a review. Alcohol Alcohol 43, 15-24.
156. Valdez, G. R., Roberts, A. J., Chan, K., Davis, H., Brennan, M., Zorrilla, E. P., and Koob, G. F. (2002). Increased ethanol self-administration and anxiety-like behavior during acute ethanol withdrawal and protracted abstinence: regulation by corticotropin-releasing factor. Alcohol Clin. Exp. Res. 26, 1494-1501.
157. Vengeliene, V., Bilbao, A., Molander, A., and Spanagel, R. (2008). Neuropharmacology of alcohol addiction. Br. J. Pharmacol. 154, 299-315.
158. Walker, B. M. (2012). Conceptualizing withdrawal-induced escalation of alcohol self-administration as a learned, plasticity-dependent process. Alcohol DOI:10.1016/j.alcohol.2012.01.001.
159. Walker, B. M., and Ettenberg, A. (2007). Intracerebroventricular ethanol-induced conditioned place preferences are prevented by fluphenazine infusions into the nucleus accumbens of rats. Behav. Neurosci. 121, 401-410.
160. Walker, B. M., and Koob, G. F. (2008a). Pharmacological Evidence for a Motivational Role of kappa-Opioid Systems in Ethanol Dependence. Neuropsychopharmacology 33, 643-652.
161. Walker, B. M., and Koob, G. F. (2008b). Pharmacological evidence for a motivational role of kappa-opioid systems in ethanol dependence. Neuropsychopharmacology 33, 643-652.
162. Walker, B. M., Valdez, G. R., McLaughlin, J. P., and Bakalkin, G. (2012). Targeting dynorphin/kappa opioid receptor systems to treat alcohol abuse and dependence. Alcohol DOI: 10.1016/j.alcohol.2011.10.006.
163. Walker, B. M., Zorrilla, E. P., and Koob, G. F. (2011). Systemic kappa-opioid receptor antagonism by nor-binaltorphimine reduces dependence-induced excessive alcohol self-administration in rats. Addict. Biol. 16, 116-119.
164. Wallace, J. A., and Felsenfeld, G. (2007). We gather together: insulators and genome organization. Curr. Opin. Genet. Dev. 17, 400-407.
165. Watanabe, H., Henriksson, R., Ohnishi, Y. N., Ohnishi, Y. H., Harper, C., Sheedy, D., Garrick, T., Nyberg, F., Nestler, E. J., Bakalkin, G., and Yakovleva, T. (2009). FOSB proteins in the orbitofrontal and dorsolateral prefrontal cortices of human alcoholics. Addict. Biol. 14, 294-297.
166. Wee, S., and Koob, G. F. (2010). The role of the dynorphin-kappa opioid system in the reinforcing effects of drugs of abuse. Psychopharmacology (Berl) 210, 121-135.
167. Werling, L. L., Frattali, A., Portoghese, P. S., Takemori, A. E., and Cox, B. M. (1988). Kappa receptor regulation of dopamine release from striatum and cortex of rats and guinea pigs. J. Pharmacol. Exp. Ther. 246, 282-286.
168. Wetmore, C., Ernfors, P., Persson, H., and Olson, L. (1990). Localization of brain-derived neurotrophic factor mRNA to neurons in the brain by in situ hybridization. Exp. Neurol. 109, 141-152.
169. Wheeler, R. A., and Carelli, R. M. (2009). Dissecting motivational circuitry to understand substance abuse. Neuropharmacology 56 Suppl 1, 149-159.
170. Williams, A. M., Reis, D. J., Powell, A. S., Neira, L. J., Nealey, K. A., Ziegler, C. E., Kloss, N., Bilimoria, J. L., Smith, C. E., and Walker, B. M. (2012). The Effect of Intermittent Alcohol Vapor or Pulsatile Heroin on Somatic and Negative Affective Indices during Spontaneous Withdrawal in Wistar Rats. Psychopharmacology (Berl) DOI: 10.1007/s00213-012-2691-3.
171. Winstanley, C. A., LaPlant, Q., Theobald, D. E., Green, T. A., Bachtell, R. K., Perrotti, L. I., Dileone, R. J., Russo, S. J., Garth, W. J., Self, D. W., and Nestler, E. J. (2007). DeltaFosB induction in orbitofrontal cortex mediates tolerance to cocaine-induced cognitive dysfunction. J. Neurosci. 27, 10497-10507.
172. Xie, H., Wang, M., Bischof, J., Bonaldo, M. F., and Soares, M. B. (2009). SNP-based prediction of the human germ cell methylation landscape. Genomics 93, 434-540.
173. Zachariou, V., Bolanos, C. A., Selley, D. E., Theobald, D., Cassidy, M. P., Kelz, M. B., Shaw-Lutchman, T., Berton, O., Sim-Selley, L. J., Dileone, R. J., Kumar, A., and Nestler, E. J. (2006). An essential role for DeltaFosB in the nucleus accumbens in morphine action. Nat. Neurosci. 9, 205-211.
174. Zhang, D., Cheng, L., Badner, J. A., Chen, C., Chen, Q., Luo, W., Craig, D. W., Redman, M., Gershon, E. S., and Liu, C. (2010). Genetic control of individual differences in gene-specific methylation in human brain. Am. J. Hum. Genet. 86, 411-419.